| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/27/2004 | WO2004044573A1 Transistor-based biosensors having gate electrodes coated with receptor molecules |
| 05/27/2004 | WO2004044571A1 Measuring apparatus used for determining an analyte in a liquid sample, comprising polymer electronic components |
| 05/27/2004 | WO2004044569A2 Mems membrane based sensor |
| 05/27/2004 | WO2004044566A1 Device and method for the recording of the surface characteristics of a fibrous structured long object |
| 05/27/2004 | WO2004044560A1 Photometric determination of coagulation time in undiluted whole blood |
| 05/27/2004 | WO2004044558A2 A method and apparatus for determining a property of a sample |
| 05/27/2004 | WO2004044556A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | WO2004044555A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | WO2004044554A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | WO2004044553A2 Lepidoptera voltage-gated calcium channels |
| 05/27/2004 | WO2004044547A2 Oxygen monitoring device |
| 05/27/2004 | WO2004044244A1 Method of detecting human serotonin 5-ht4 receptor gene type in nucleic acid sample |
| 05/27/2004 | WO2004044241A2 Use of fish larvae as a screening model |
| 05/27/2004 | WO2004044234A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) |
| 05/27/2004 | WO2004044232A1 Microparticle-based methods and systems and applications thereof |
| 05/27/2004 | WO2004044231A2 Method for detecting intracellular cholesterol |
| 05/27/2004 | WO2004044230A1 A methodology of estimating the conformation of a protein by proteolysis |
| 05/27/2004 | WO2004044229A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 05/27/2004 | WO2004044226A2 Induction of cellular senescence by cdk4 disruption for tumor supression and regression |
| 05/27/2004 | WO2004044225A2 Methods for identifying dna copy number changes |
| 05/27/2004 | WO2004044221A2 High throughput automatic nucleic acid isolation and quantitation methods |
| 05/27/2004 | WO2004044218A2 Methods and materials for examining pathways associated with glioblastoma progression |
| 05/27/2004 | WO2004044204A2 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 05/27/2004 | WO2004044203A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/27/2004 | WO2004044201A1 Signaling proteins participating in immunopotentiation by virus-origin double-stranded rna and endotoxin and genes thereof |
| 05/27/2004 | WO2004044199A1 Screening method |
| 05/27/2004 | WO2004044196A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b) |
| 05/27/2004 | WO2004044193A1 Modified sarcosine oxidase, process for producing the same and reagent composition using the same |
| 05/27/2004 | WO2004044187A1 Rapid detection of bacterial spores |
| 05/27/2004 | WO2004044178A2 Methods and compositions for diagnosing dysplasia |
| 05/27/2004 | WO2004044175A2 Fluorescence guided cell capture |
| 05/27/2004 | WO2004044168A2 Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities |
| 05/27/2004 | WO2004044128A2 An associative analysis of gene expression array data |
| 05/27/2004 | WO2004044116A1 Anaerobic fermentation method and apparatus |
| 05/27/2004 | WO2004044011A2 Combinatorial libraries of monomer domains |
| 05/27/2004 | WO2004044002A1 Growth hormone variations in humans and its uses |
| 05/27/2004 | WO2004044001A2 Acetylated hmgb1 protein |
| 05/27/2004 | WO2004043988A2 Ptprk immunogenic peptide |
| 05/27/2004 | WO2004043831A2 Systems and methods of sorting samples |
| 05/27/2004 | WO2004043563A2 Methods of isolation of active compounds and activated targets |
| 05/27/2004 | WO2004043401A2 Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use |
| 05/27/2004 | WO2004043395A2 Methods and compositions for treating neurological disorders |
| 05/27/2004 | WO2004043387A2 Compositions and methods for cancer diagnosis and therapy |
| 05/27/2004 | WO2004043386A2 Molecules preferentially associated with effector t cells and methods of their use |
| 05/27/2004 | WO2004043385A2 Methods and compositions for prostate epithelial cell differentiation |
| 05/27/2004 | WO2004043383A2 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/27/2004 | WO2004043371A2 Methods and compositions for modulating p53 transcription factor |
| 05/27/2004 | WO2004043370A2 Methods and compositions for modulating activator protein 1 |
| 05/27/2004 | WO2004043344A2 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 05/27/2004 | WO2004043286A2 Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen |
| 05/27/2004 | WO2004043238A2 Biomarkers for intra-amniotic inflammation |
| 05/27/2004 | WO2004043237A2 Uncoupled collagen synthesis and degradation assays |
| 05/27/2004 | WO2004043236A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | WO2004043233A2 Assay for autoantibodies to folate receptors |
| 05/27/2004 | WO2004043230A2 A method of screening for disorders of glucose metabolism |
| 05/27/2004 | WO2004043226A2 Methods for predicting whether subjects with mild cognitive impairment (mci) will develop alzheimer's disease |
| 05/27/2004 | WO2004043223A2 Compositions and methods for the diagnosis and treatment of sepsis |
| 05/27/2004 | WO2004035808A3 Method for detecting viral inactivating agents |
| 05/27/2004 | WO2004031776A3 Screening method |
| 05/27/2004 | WO2004029620A3 Screening method involving transfected primary t cells |
| 05/27/2004 | WO2004027389A3 Assay products and procedures |
| 05/27/2004 | WO2004025561B1 Chemical synthesis using diffraction grating-based encoded optical elements |
| 05/27/2004 | WO2004023136A3 Method and apparatus for determining the viability of eggs |
| 05/27/2004 | WO2004019004A9 An arsenic meter |
| 05/27/2004 | WO2004017070A3 Sensor surface comprising an improved signal-noise ratio |
| 05/27/2004 | WO2004016727A9 Determination and/or control of reactor environmental conditions |
| 05/27/2004 | WO2004014941A8 Method for selective peptide labeling |
| 05/27/2004 | WO2004010537B1 Flexible biochip |
| 05/27/2004 | WO2004009762A3 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 05/27/2004 | WO2004008147A3 Diagnosis and prevention of cancer cell invasion |
| 05/27/2004 | WO2004005890A3 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 05/27/2004 | WO2004001655A8 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 05/27/2004 | WO2003107000A3 Determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein |
| 05/27/2004 | WO2003104363A3 Determining fluid composition from fluid properties |
| 05/27/2004 | WO2003089663A3 Methods for measuring enzyme activity |
| 05/27/2004 | WO2003086278A8 Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions |
| 05/27/2004 | WO2003081258A3 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 05/27/2004 | WO2003079402A3 Latex based adsorbent chip |
| 05/27/2004 | WO2003076953A3 An electrical condition monitoring method for polymers |
| 05/27/2004 | WO2003076899A9 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
| 05/27/2004 | WO2003075833A3 Screening method for orthopoxvirus antivirals |
| 05/27/2004 | WO2003073996A3 Human schwannoma cell line |
| 05/27/2004 | WO2003068820A9 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 05/27/2004 | WO2003054550A3 Uses of an endothelial cell receptor |
| 05/27/2004 | WO2003046567A3 Protein biopolymer markers predictive of alzheimers disease |
| 05/27/2004 | WO2003045310A8 Digital assay |
| 05/27/2004 | WO2003045229A3 Methods and compositions for treating cancer |
| 05/27/2004 | WO2003035050A3 Use of tyrosine kinase inhibitors for promoting hair growth |
| 05/27/2004 | WO2003019142A9 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque |
| 05/27/2004 | WO2003010507A3 System for intracellular process monitoring and in vivo drug screening |
| 05/27/2004 | WO2003004604A3 Phage displayed pdz domain ligands |
| 05/27/2004 | WO2002102854A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 05/27/2004 | WO2002097037A8 Melanin-concentrating hormone analogs |
| 05/27/2004 | WO2002093131A3 Methods for isolating and labeling sample molecules |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | WO2002084288A9 Individualization of therapy with antiarrhythmics |
| 05/27/2004 | WO2002081413A3 One dimensional unichemo protection (ucp) in organic synthesis |
| 05/27/2004 | WO2002079754A3 Contact potential difference sensor to monitor oil properties |
| 05/27/2004 | WO2002079393A3 Dynamic action reference tools |
| 05/27/2004 | WO2002072892A9 Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |